These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4456482)

  • 41. Effect of oral antidiabetic drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of the effects of sulfonylurea exposure on pancreatic beta cell metabolism.
    Brennan L; Hewage C; Malthouse JP; McClenaghan NH; Flatt PR; Newsholme P
    FEBS J; 2006 Nov; 273(22):5160-8. PubMed ID: 17054712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
    Pedrazzi F; Bommartini F; Freddo J; Emanueli A
    Eur J Rheumatol Inflamm; 1981; 4(1):26-31. PubMed ID: 7042358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cholinomimetic drugs on reptilian atrial muscles.
    Ojewole JA; Akinwande KI
    Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):379-87. PubMed ID: 6503473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacology of HB 419, a new strongly effective oral antidiabetic].
    Bänder A; Pfaff W; Schmidt FH; Stork H; Schröder HG
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1363-8. PubMed ID: 5394454
    [No Abstract]   [Full Text] [Related]  

  • 46. Rational choice of oral antihyperglycaemic agents.
    Chowdhury S; Sengupta N
    J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic effects of oral hypoglycemic drugs.
    Davidoff F
    Fed Proc; 1977 Dec; 36(13):2724-7. PubMed ID: 336410
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of amiloride and its derivative dichlorobenzamil on guinea pig atria: interaction with other inotropic mechanisms].
    Padrón-Nieves M; Alfonso C; Lamanna V; Pérez-González M
    Acta Cient Venez; 1999; 50(1):48-58. PubMed ID: 10513038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
    Pou Torelló JM; Vilaclara JM
    Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
    [No Abstract]   [Full Text] [Related]  

  • 50. Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.
    Uwaifo GI; Ratner RE
    Am J Cardiol; 2007 Feb; 99(4A):51B-67B. PubMed ID: 17307058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical pharmacology of two new oral antidiabetics of the sulfonamide type (author's transl)].
    Haupt E; Küllmer KA; Schöffling K
    Klin Wochenschr; 1977 Jul; 55(14):695-703. PubMed ID: 895007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulphonylurea-sensitive channels and NO-cGMP pathway modulate the heart rate response to vagal nerve stimulation in vitro.
    Almond SC; Paterson DJ
    J Mol Cell Cardiol; 2000 Nov; 32(11):2065-73. PubMed ID: 11040109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tolbutamide: an inotropic effect on rabbit atria.
    Palmer RF; Lasseter KC; McCarthy J
    Lancet; 1971 Mar; 1(7699):604. PubMed ID: 4100941
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro].
    Weinges KF; Biro G; Kettl H; Mitzuno M
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1467-9. PubMed ID: 4899089
    [No Abstract]   [Full Text] [Related]  

  • 55. [The effect of hypoglycemic sulfonylurea preparations on the heart conduction system].
    Pogátsa G; Németh M
    Orv Hetil; 1980 Sep; 121(37):2255-7. PubMed ID: 6780962
    [No Abstract]   [Full Text] [Related]  

  • 56. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition.
    Fujitani S; Okazaki K; Yada T
    Br J Pharmacol; 1997 Apr; 120(7):1191-8. PubMed ID: 9105692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.
    PFEIFFER EF; PFEIFFER M; DITSCHUNEIT H; AHN CS
    Ann N Y Acad Sci; 1959 Sep; 82():479-95. PubMed ID: 14432532
    [No Abstract]   [Full Text] [Related]  

  • 58. [Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels].
    Larsson O; Kindmark H; Bränström R; Berggren PO
    Lakartidningen; 1997 Nov; 94(48):4473-7. PubMed ID: 9424548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
    Lentini S; Bossini A; Pirola LC
    Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
    [No Abstract]   [Full Text] [Related]  

  • 60. Cardiac DT-diaphorase contributes to the detoxification system against doxorubicin-induced positive inotropic effects in guinea-pig isolated atria.
    Badary OA; Awad AS; Abdel-Maksoud S; Hamada FM
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):856-61. PubMed ID: 15659049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.